Effects of Extended Release Niacin added to Simvastatin/Ezetemibe on Glucose and Insulin values in AIM HIGH

BACKGROUND: Niacin is an anti-dyslipidemic agent that may cause blood sugar elevation in patients with diabetes, but its effects on glucose and insulin values in non-diabetic statin-treated subjects with cardiovascular disease and at high risk for diabetes are less well known. METHODS: This was a pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Med
Hlavní autoři: Goldberg, Ronald B., Bittner, Vera A., Dunbar, Richard L., Fleg, Jerome L., Grunberger, George, Guyton, John R., Leiter, Lawrence A., McBride, Ruth, Robinson, Jennifer G., Simmons, Debra L., Wysham, Carol, Xu, Ping, Boden, William E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914402/
https://ncbi.nlm.nih.gov/pubmed/27036394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2016.02.039
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky